Summit Therapeutics PLC Cash Flow Quality Index
Summit Therapeutics PLC cash flow quality index. Summit Therapeutics PLC (SMMT) has a Cash Flow Quality Index of -0.38x as of June 2018. Operating cash flow of $-13.86 Million is below net income of $36.06 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Summit Therapeutics PLC to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Summit Therapeutics PLC (2018–2018)
Cash flow quality index of Summit Therapeutics PLC from 2018 to 2018. Historical Cash Flow Quality Index for Summit Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore SMMT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Summit Therapeutics PLC Cash Flow Quality Index by Year (2018–2018)
Summit Therapeutics PLC cash flow quality index by year from 2018 to 2018. Year-by-year earnings quality comparison for Summit Therapeutics PLC. For the full cash flow conversion analysis, see SMMT cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -3.23x | $-35.11 Million | $10.87 Million | — |